Raloxifene approval ushers in new drug class for osteoporosis. Estrogen-receptor effects vary by tissue type.
D000328:Adult; D000368:Aged; D015519:Bone Density / Q000187:drug effects*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use*; D020849:Raloxifene Hydrochloride
D004965:Estrogen Antagonists; D010880:Piperidines; D020849:Raloxifene Hydrochloride